Are You Looking For Medical Devices Certifications?
Get it here!Looking for Regulatory Consultant ?
Integrated Management Systems (IMS) Certification combines multiple management system standards into a unified approach, streamlining the process of ensuring compliance with ISO standards. By integrating systems such as ISO 9001, ISO 13485, and other relevant standards, IMS simplifies the management of quality, environmental, and regulatory requirements in one cohesive framework. This certification allows organizations to operate more efficiently while meeting ISO certification requirements across various domains. For medical device companies, implementing IMS ensures compliance with ISO 9001 requirements, ISO 13485, and other international regulations, providing a comprehensive approach to achieving the ISO 9001 certification requirements. This integration also supports ongoing improvements and harmonization of processes, ensuring a streamlined, effective system for long-term success.
Achieving IQMS certification brings numerous advantages to medical device companies. It ensures that your organization adheres to the highest quality standards, facilitating smooth market entry across multiple regions. By complying with ISO 9001 requirements and other regulatory standards, you enhance product consistency, improve customer satisfaction, and gain a competitive edge. Furthermore, meeting ISO certification requirements helps streamline operations, minimize risks, and reduce the likelihood of costly non-compliance issues. With ISO 9001 certification requirements integrated into your quality management system, you can confidently demonstrate to stakeholders that your processes meet global industry standards, fostering trust and reliability in your medical device offerings.
Under MDSAP, manufacturers of Class II, III, and IV medical devices must demonstrate compliance with ISO 13485. The QMS requirements of the Canadian Medical Devices Regulations (CMDR) are incorporated into the MDSAP. Before your device can be sold in Canada, it must undergo certification from a Health Canada and MDSAP-accredited Auditing Organization (AO) to verify your MDSAP-compliant quality system. As of January 1, 2019, MDSAP compliance is mandatory. In addition, manufacturers should also be mindful of the ISO 9001 documentation requirements, which may help streamline processes and align with broader international standards. To ensure compliance, manufacturers must meet the QMS requirements, and they can get ISO certification through an accredited body to support their market access and quality assurance processes.
As part of their Canadian Medical Device Conformity Assessment System (CMDCAS) accreditation programme, Health Canada will conduct an MDSAP audit. Upon the successful completion of the pilot, Health Canada intends to establish the Medical Device Single Audit Program as a means to achieve regulatory compliance for quality management system requirements in Canada.
A document outlining the current good manufacturing practices (CGMP) requirements is the FDA 21 CFR Part 820, often known as the Quality System Regulation (QSR). This document oversees manufacturing processes to guarantee that their goods comply consistently with applicable specifications and regulations. The quality system approved by the FDA is FDA 21 CFR Part 820. These guidelines are designed to assure safe and effective medical devices. Medical device makers to ensure compliance with FDA 21 CFR 820 conduct FDA inspections. In addition to meeting the FDA requirements, manufacturers can seek quality management system certification to demonstrate their commitment to maintaining high standards. Integrating an integrated quality management system helps streamline processes, ensuring that quality control is maintained across every aspect of production. Furthermore, QMS ISO 9001 certification can be pursued to meet global quality standards, showcasing a dedication to continuous improvement and customer satisfaction.
FDA will accept the MDSAP audit reports as a substitute for FDA routine inspections. However, inspections conducted “for cause” or “compliance follow-up” by FDA will not be impacted by this program. Additionally, the MDSAP would not apply to any required pre-approval or post-approval inspections in support of Premarket Approval (PMA) applications. It is important for manufacturers to ensure their quality management systems meet the ISO 9001 quality management system requirements, as this standard is integral to the MDSAP audit process. Compliance with ISO certification quality management system standards and fulfilling the quality management systems requirements ensures that medical device manufacturers maintain high levels of quality and safety throughout the product lifecycle.
If you have already implemented ISO 13485 to sell in Europe and want to sell your device in the United States, Canada, Brazil, Japan, or Australia, we can assist you in upgrading your QMS to fulfill all country-specific standards. We will expand on your current ISO 13485 quality system by adding particular procedures and paperwork required to comply with 21 CFR 820 and MDSAP. We can also assist you in ensuring that your ISO 13485 certification is issued by an MDSAP-accredited Auditing Organization (AO). Furthermore, we can guide you in meeting FDA QMS requirements for devices sold in the U.S. and ensure that your system aligns with MDR QMS requirements for the European market. If you’re also seeking broader certification, we can support you in obtaining ISO 9001 quality management system certification for your organization.
TGA requires assessment of compliance of the medical device to the Medical Device authorisation requirements where the MDSAP audit report is used as an evidence. However, if the device is exempted this might not be required.
ANIVSA pre-market and post-market assessment procedures require the MDSAP audit reports to be utilised as an input for regulatory technical evaluation.
MDSAP audit outcomes aid in assessment of regulatory compliance for quality management systems in Canada.
MDSAP audit reports are accepted as alternative of FDA routine inspections where these are not applicable for pre-approval and post-approval inspections, Pre-market approval or PMA applications.
MDSAP reports are used as a trial to allow exemption from on-site inspection of the manufacturing site; To replace substantial part of documents required for the inspection with the MDSAP audit report by the Marketing Authorization Holder
Connect With Us